The Schistosomiasis Disease Market segment can be broadly divided into therapeutics, diagnostics, and vector control. Within the therapeutic segment, praziquantel remains the dominant product, but there is a growing niche for combination therapies that may include artemisinins or other anti-parasitic agents to increase clearance rates. In the diagnostic segment, the market is splitting into...
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt